Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with r...
Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): updated outcomes from a randomised, multicentre, open-label, phase 3 study
About this item
Full title
Author / Creator
Usmani, Saad Z, MD , Quach, Hang, MD , Mateos, Maria-Victoria, MD , Landgren, Ola, Prof , Leleu, Xavier, MD , Siegel, David, MD , Weisel, Katja, Prof , Gavriatopoulou, Maria, MD , Oriol, Albert, MD , Rabin, Neil, MBBS , Nooka, Ajay, MD , Qi, Ming, MD , Beksac, Meral, MD , Jakubowiak, Andrzej, MD , Ding, Bifeng, MS , Zahlten-Kumeli, Anita, PhD , Yusuf, Akeem, PhD and Dimopoulos, Meletios, Prof
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
SummaryBackgroundDespite recent advances in therapeutic options, there remains an unmet need for treating patients with relapsed or refractory multiple myeloma, especially in those previously exposed or refractory to lenalidomide. This updated efficacy and safety analysis from the phase 3 CANDOR study compared carfilzomib, daratumumab, and dexameth...
Alternative Titles
Full title
Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): updated outcomes from a randomised, multicentre, open-label, phase 3 study
Authors, Artists and Contributors
Author / Creator
Quach, Hang, MD
Mateos, Maria-Victoria, MD
Landgren, Ola, Prof
Leleu, Xavier, MD
Siegel, David, MD
Weisel, Katja, Prof
Gavriatopoulou, Maria, MD
Oriol, Albert, MD
Rabin, Neil, MBBS
Nooka, Ajay, MD
Qi, Ming, MD
Beksac, Meral, MD
Jakubowiak, Andrzej, MD
Ding, Bifeng, MS
Zahlten-Kumeli, Anita, PhD
Yusuf, Akeem, PhD
Dimopoulos, Meletios, Prof
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2607578969
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2607578969
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(21)00579-9
